166 results
Page 4 of 9
S-3ASR
EX-5.1
l3vs 0q658er826wzn9o
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
tegj60ogjwtveqopz
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
EX-1.2
tqk w8zoztzmroey
10 Aug 20
Automatic shelf registration
5:01pm
424B5
2atcxfg7ugsgqoo61j76
2 Jun 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-5.1
ojoj3
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
8-K
EX-1.1
s0h6r0t04
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
424B5
qav8t8b1djomf ee
1 Jun 20
Prospectus supplement for primary offering
6:06am
8-K
EX-99.1
30f0dzr
14 May 20
Adaptimmune Reports Q1 Financial Results
7:37am
8-K
98qrqtqtvvb07fvycc2
29 Apr 20
Other Events
8:06am
8-K
EX-10.1
horvdu
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
8-K
xowfz
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
424B5
8g8fenz39
22 Jan 20
Prospectus supplement for primary offering
5:31pm
8-K
EX-5.1
69a r414jn57t
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm